Thursday, 31st August 5th International Symposium on Phaeochromocytoma and Paraganglioma 2017

• New PET modalities for pheochromocytoma and paraganglioma - Karel Pacak
• The biological basis for PET imaging in PCC/PGL - Rod J Hicks
• In- and ex-vivo metabolic profiling of PPGL - Henri Timmers
• Role of ⁶⁸Gallium Dotatate-PET/CT in pre-operative assessment of phaeochromocytoma and paraganglioma - Matti L Gild
• Impact of ¹²³ I-MIBG scintigraphy on clinical decision making in patients with pheochromocytoma and paraganglioma    - Anouk van Berkel

• Novel and less well known cluster 2-related PPGLs  - Patricia Dahia
• LESSONS FROM MTC APPLICABLE TO PHEOCHROMOCYTOMA - Bruce Robinson
• Contribution of targeted next-generation sequencing (NGS) to improve detection of germline and somatic mutations in pheochromocytomas and paragangliomas - Nelly BURNICHON
• A Bayesian approach to determining penetrance of pathogenic variants in genes for hereditary pheochromocytoma/paraganglioma syndromes - Roderick Clifton-Bligh

The conference acknowledges the support of

• Current Status of Genetic testing in Pheochromocytomas/ Paragangliomas in Japan - Kazuhiro Takekoshi
• Multi-institutional study of carotid body tumors in Japan - Aya Ikeda
• Outcomes of long-term surveillance of succinate dehydrogenase mutation carriers followed in a familial endocrine risk management clinic - Nirupa Sachithanandan
• MIBG avidity and progression-free survival in patients with metastatic pheochromocytoma are not dependent on germline SDHx mutation status - Lauren Fishbein
• Risk factors for intraoperative hemodynamic instability for resection of pheochromocytoma and paraganglioma - Rungsima Tinmanee
• Genetic Aetiology of Paediatric Phaeochromocytoma and Paraganglioma: Experience of a Tertiary Centre and Review of Literature - Anand Vasudevan
• The microenvironment induces collective migration in SDHB silenced mouse pheochromocytoma spheroids - Elena Rapizzi
• Utility of chromogranin A as a predictive marker for paraganglioma surveillance in succinate dehydrogenase B and D - John R Burgess
• Coexistence of Hepatic Metastasis from Malignant Pheochromocytoma and Hepatocellular carcinoma, A Case Report - Natnicha Houngngam
• Metabolomic analysis identifies novel tumour-causing mutations in fumarate hydratase in two patients with phaeochromocytoma - Susan Richter
• Survey of RCPAQAP participants regarding their measurement and reporting of plasma metanephrines - Wilson Punyalack
• A giant malignant paraganglioma mimicking hepatic cancer – a case report - Shi Chen
• SDHAF3 interacts with SDHB: Could an SDHAF3 variant play a role in pheochromocytoma and paraganglioma?  - Trish Dwight
• SDHA p.Arg31* is pathogenic but subpenetrant - Catherine Luxford
• SDHC Immunohistochemistry in Pheochromocytoma and Paraganglioma: A Supplementary Tool to Detect Germline SDHx mutation - Zheng Pei Zeng
• Pheochromocytoma associated with systemic lupus erythematosus in a patient with multiple endocrine neoplasia 2A: a case report. - Lin Lu
• Functional-structural mapping of TMEM127 Mutation - Patricia Dahia
• Biochemical diagnosis of pheochromocytoma: Plasma free versus urinary deconjugated and urinary free normetanephrine, metanephrine and methoxytyramine - Graeme Eisenhofer

• Cluster I PPGLS - spanners in the Krebs cycle - Judith Favier
• Metabologenomics of Chromaffin Cell Tumors - Graeme Eisenhofer
• Mitochondrial defects in cancer - Rae-Anne Hardie
• Investigating the metabolism of SDH-mutated disease for novel target identification - Daniel Tennant

The conference acknowledges the support of

• miR-21-3p and miR-183-5p: novel risk markers for metastatic pheochromocytoma and paraganglioma - Bruna Calsina
• In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma - Charlotte LUSSEY-LEPOUTRE
• Succinate mediated autocrine tumorigenic effects in succinate dehydrogenase deficient paragangliomas: Potential for new targeted treatment strategies - Stephanie MJ Fliedner
• A gain-of-function mutation in an epigenetic modulator in patients with paraganglioma - Laura Remacha
• Optimized procedures for diagnostic testing for pheochromocytomas/paragangliomas in patients with chronic kidney disease - Christina Pamporaki

Emma Edwards

Genetic counselling in Phaeochromoctyoma and Paraganglioma

Caley Schnaid 

Food and nutrition for nets: phaeochromocytomas and paragangliomas

Jane Fletcher

Living with uncertainty: managing fear

Karen Adams

Management of clinical sequelae of catecholamine excess